The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions

Anaesthesia and elective surgery: the aspiration question — does this still hold?

Solved
Solved by s.ostergaard in post #4
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

Jump to the accepted answer →

K
KnowltonTL3Regular10 Sep 2024#1

Anaesthesia and elective surgery: the aspiration question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.

Practical question with the units stated, because I have seen how quickly these go wrong without them.

I have a 2 mg vial of retatrutide and I am working to a 0.5 mg step. My syringes are U-100 insulin syringes, 0.5 mL barrel.

I can do the arithmetic and I have done it twice, getting the same answer both times, but I would like someone to check the reasoning rather than the number — specifically whether I have thought about the residual volume correctly, and whether the graduation I am landing on is one a person can actually read.

29 likes 23mo
HD
h.delgadoTL2 Moderator24 Sep 2024#2

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

6 likes 22mo
BV
bias_varianceTL4Biostatistician4 Oct 2024#3
h.delgado, post #2: Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach. Go to post

I read the opening post twice before replying, because I had assumed the opposite.

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

0 likes in reply to #2 22mo
SO
s.ostergaardTL2 Moderator Solution13 Oct 2024#4
h.delgado, post #2: Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach. Go to post

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

31 likes in reply to #2 21mo
FD
f.demirTL2Regular21 Oct 2024#5

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

10 likes 21mo
MS
m.steinerTL2 Moderator29 Oct 2024 · edited#6

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

3 likes 21mo
RM
r.mcalisterTL3Regular6 Nov 2024#7
m.steiner, post #6: Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this. Go to post

Coming back to post #5, because the follow-up matters more than the original answer.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

0 likes in reply to #6 21mo
AI
a.iyerTL2 Moderator13 Nov 2024#8
f.demir, post #5: SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Picking up post #5: that is the part I would want checked first.

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

23 likes in reply to #5 20mo
BN
b.nilsenTL2 Moderator20 Nov 2024#9

Worth separating two things that post #5 runs together.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

6 likes 20mo
NP
n.petrovTL2 Moderator27 Nov 2024#10

post #9 is right about the mechanism and I think understates the practical bit.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

1 like 20mo
BP
b.petrovTL2 Moderator3 Dec 2024#11

post #10 answers the question as asked. The question underneath it is different.

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

3 likes 20mo
JN
j.nwosuTL2 Moderator10 Dec 2024#12

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

11 likes 20mo
AK
a.kowalskiTL2 Moderator16 Dec 2024 · edited#13

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

32 likes 19mo
EP
e.piresTL2 Moderator22 Dec 2024#14
r.mcalister, post #7: Coming back to post #5, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had been repeating something I had not checked carefully enough. Go to post

Coming back to post #12, because the follow-up matters more than the original answer.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

0 likes in reply to #7 19mo
SK
s.kimaniTL2 Moderator28 Dec 2024#15
a.kowalski, post #13: Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well. Go to post

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

1 like in reply to #13 19mo
JM
j.mwangiTL4 Moderator3 Jan 2025#16
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

7 likes 19mo
DE
d.eriksenTL2 Moderator9 Jan 2025#17

This follows post #14 rather than contradicting it.

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

24 likes 19mo
MS
m.strand_rphTL3Pharmacist15 Jan 2025#18

I read post #16 twice before replying, because I had assumed the opposite.

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

0 likes 18mo
GH
g.haalandTL3Regular21 Jan 2025#19
b.petrov, post #11: post #10 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination. Go to post

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

0 likes in reply to #11 18mo
EC
e.coelhoTL2 Moderator27 Jan 2025#20

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

3 likes 18mo
RV
r.venkatesanTL3Wiki editor1 Feb 2025#21
a.kowalski, post #13: Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well. Go to post

Worth separating two things that post #17 runs together.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

0 likes in reply to #13 18mo
KP
k.pereiraTL2 Moderator7 Feb 2025#22

post #21 is right about the mechanism and I think understates the practical bit.

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

20 likes 18mo
IS
isotonic_sheetTL3Regular13 Feb 2025#23

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

8 likes 17mo
PK
p.krastevTL218 Feb 2025#24
RJ
r.jhannsdttirTL3Regular23 Feb 2025#25

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

28 likes 17mo
NK
ni.kravchenkoTL2 Moderator1 Mar 2025#26

post #25 answers the question as asked. The question underneath it is different.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

14 likes 17mo
EA
e.almeidaTL2Member6 Mar 2025 · edited#27

Coming back to post #25, because the follow-up matters more than the original answer.

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

5 likes 17mo
RS
r.sobczakTL2 Moderator11 Mar 2025#28
r.venkatesan, post #21: Worth separating two things that post #17 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active… Go to post

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

0 likes in reply to #21 17mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Common supplements people ask about, assessed one at a time — a second dataset
Posting this under the heading it deserves: Common supplements people ask about, assessed one at a time — a second dataset Everything below is what sits behind that. Reporting something rather than asking…
VMJRCTDBTD+97 104 15k 3mo
[2026 update] Antibiotics and a course of something with delayed emptying
On the subject in the title: Antibiotics and a course of something with delayed emptying Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful…
NSEVABKPDT+88 97 19k 13h
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs matter
Delayed gastric emptying and oral medication absorption: which drugs matter Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
TVMABMKAAR+63 74 11k 1d
About the Interactions category
Drug, supplement and food interactions — separating timing inconveniences from clinically important ones. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
JMKCWDBMS+4 8 1.9k 2mo
Oral contraceptives and delayed emptying: what the data shows
Posting this under the heading it deserves: Oral contraceptives and delayed emptying: what the data shows Everything below is what sits behind that. Reporting something rather than asking about it, in case…
CAWMDEMSBV+63 71 5.9k 2y

Related topics — sharing the tags needs a source, hypoglycaemia, metformin

TopicParticipantsRepliesViewsActivity
Metformin co-administration and additive GI effects
Metformin co-administration and additive GI effects Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it, in case the pattern is…
JRAFPOCLOV+28 32 2.1k 15mo
Sulfonylureas: the interaction most worth taking seriously
Sulfonylureas: the interaction most worth taking seriously Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
DOZCERFHKR+4 8 38k 6h
A preprint whose numbers changed substantially at publication
A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2 ( Lancet , 2023). Please read it before posting;…
IBCNNDBRC+90 95 21k 9mo
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset
On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019)…
WNCDSOOSB+77 84 54k 11mo
Coming back to: Grapefruit: why this class is not the class that cares
Posting this under the heading it deserves: Grapefruit: why this class is not the class that cares Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so…
AKHEYMJFCL+44 48 12k 18mo